FR2313923A1 - Compsn. contg. sodium noramidopyrin mesylate monohydrate - also contg. chlormezanone and meprobamate, having analgesic, antiinflammatory, muscle-relaxant and anxiolytic activity - Google Patents

Compsn. contg. sodium noramidopyrin mesylate monohydrate - also contg. chlormezanone and meprobamate, having analgesic, antiinflammatory, muscle-relaxant and anxiolytic activity

Info

Publication number
FR2313923A1
FR2313923A1 FR7518532A FR7518532A FR2313923A1 FR 2313923 A1 FR2313923 A1 FR 2313923A1 FR 7518532 A FR7518532 A FR 7518532A FR 7518532 A FR7518532 A FR 7518532A FR 2313923 A1 FR2313923 A1 FR 2313923A1
Authority
FR
France
Prior art keywords
contg
noramidopyrin
chlormezanone
meprobamate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7518532A
Other languages
French (fr)
Other versions
FR2313923B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LUCIEN LABORATOIRES
Original Assignee
LUCIEN LABORATOIRES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LUCIEN LABORATOIRES filed Critical LUCIEN LABORATOIRES
Priority to FR7518532A priority Critical patent/FR2313923A1/en
Publication of FR2313923A1 publication Critical patent/FR2313923A1/en
Application granted granted Critical
Publication of FR2313923B1 publication Critical patent/FR2313923B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Abstract

New therapeutic compsn. comprises camylofin noramidopyrin mesylate (Avapyrazone), sodium noramidopyrin mesylate monohydrate, chlormezanone and meprobamate, specifically in the ratio of 60 mg:210 mg:50 mg:50 mg respectively. Used as synergistic mixt. the compsn. has muscle relaxant, anxiolytic, analgesic and antiinflammatory activity and is esp. useful in treating pain and spasm of smooth muscle e.g. in gastrointestinal tract, of striated muscle, and of joints. A pref. dosage unit contg. 60 mg of camylofin noramidopyrin mesylate (Avapyrazone) 210 mg of sodium noramidopyrin mesylate monohydrate, 50 mg of chlormezanone and 50 mg of meprobamate, was given to adults at up to 6 dosage units daily.
FR7518532A 1975-06-13 1975-06-13 Compsn. contg. sodium noramidopyrin mesylate monohydrate - also contg. chlormezanone and meprobamate, having analgesic, antiinflammatory, muscle-relaxant and anxiolytic activity Granted FR2313923A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7518532A FR2313923A1 (en) 1975-06-13 1975-06-13 Compsn. contg. sodium noramidopyrin mesylate monohydrate - also contg. chlormezanone and meprobamate, having analgesic, antiinflammatory, muscle-relaxant and anxiolytic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7518532A FR2313923A1 (en) 1975-06-13 1975-06-13 Compsn. contg. sodium noramidopyrin mesylate monohydrate - also contg. chlormezanone and meprobamate, having analgesic, antiinflammatory, muscle-relaxant and anxiolytic activity

Publications (2)

Publication Number Publication Date
FR2313923A1 true FR2313923A1 (en) 1977-01-07
FR2313923B1 FR2313923B1 (en) 1978-10-06

Family

ID=9156485

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7518532A Granted FR2313923A1 (en) 1975-06-13 1975-06-13 Compsn. contg. sodium noramidopyrin mesylate monohydrate - also contg. chlormezanone and meprobamate, having analgesic, antiinflammatory, muscle-relaxant and anxiolytic activity

Country Status (1)

Country Link
FR (1) FR2313923A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9499480B2 (en) 2006-10-12 2016-11-22 Bhi Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005326962A1 (en) 2004-12-22 2006-08-17 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9499480B2 (en) 2006-10-12 2016-11-22 Bhi Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US10238611B2 (en) 2006-10-12 2019-03-26 Bellus Health Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US10857109B2 (en) 2006-10-12 2020-12-08 Bellus Health, Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US11020360B2 (en) 2006-10-12 2021-06-01 Bellus Health Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

Also Published As

Publication number Publication date
FR2313923B1 (en) 1978-10-06

Similar Documents

Publication Publication Date Title
DE3163524D1 (en) Imidazo(1,2-a)pyridine derivatives, process for their preparation and their therapeutical use
ES538807A0 (en) A PROCEDURE FOR THE PRODUCTION OF A COVALENTLY UNITED ALPHA-1-PROTEINASE INHIBITOR COMPLEX WITH A WATER SOLUBLE POLYMER.
ATE190064T1 (en) COMBINATION THERAPEUTIC NUCLEOSIDES WITH OTHER THERAPEUTICALLY EFFECTIVE COMPONENTS.
IE41374L (en) Composition for treating schizophrenia
EG19912A (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
ES2061989T3 (en) USE OF ALKYL ESTERS OF PYROGLUTAMIC ACID FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ICTIOSIS.
DE69424777T2 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
IT1189298B (en) PROCEDURE FOR THE PRODUCTION OF DERMATAN-SULPHATE AND EPARAN-SULPHATE MINOGLICANS GLYCOS SUBSTANTIALLY PURE AND THEIR PHARMACEUTICAL USE
FR2313923A1 (en) Compsn. contg. sodium noramidopyrin mesylate monohydrate - also contg. chlormezanone and meprobamate, having analgesic, antiinflammatory, muscle-relaxant and anxiolytic activity
IE38943B1 (en) Pyrroles and process for their manufacture
AU1395583A (en) Use of oleanolic acid for ulcer treatment
MY100483A (en) Niflumic acid morpholinoethyl ester diniflumate, preparation, use in therapeutics as analgesic and anti- inflammatory
DE3467705D1 (en) Use of 4,5'-azo-bis-salicylic acid for the manufacture of a medicament for the treatment of inflammatory disorders in the intestine
ATE40687T1 (en) NEW PYRIDE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
JPS5610114A (en) Novel analgesic and anti-inflammatory agent
HUT35519A (en) Process for producing of anelgetic medical preparatives
FR2320098A1 (en) Pyridylimino or quinolylimino-tetrahydro-thiazolo-isoquinoline cpds. - are analgesics and antipyretics with some antiinflammatory activity
DE3260567D1 (en) Analgesic potentiation
EP0673646A3 (en) Use of Deoxypergualin in the manufacture of a medicament for the treatment of inflammatory-hyperresponsiveness diseases.
FR2351655A1 (en) Pyridylimino or quinolylimino-tetrahydro-thiazolo-isoquinoline cpds. - are analgesics and antipyretics with some antiinflammatory activity
JPS5235455A (en) Rotary fixed bed-type denitrogen treatment equipment
JPS5249654A (en) Preliminary treatment of human and animal excrements with bacteria in intestines
NL7603491A (en) N-nicotinoyl-4-amino benzoic acid derivs - in compns for promoting cerebral blood flow esp in the elderly
AU514653B2 (en) Pharmaceutical preparations forthe treatment of disorders in calcium metabolism

Legal Events

Date Code Title Description
ST Notification of lapse